Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

TOKYO and CAMBRIDGE, Mass., Sept. 3, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the rolling submission of the Supplemental Biologics License…

Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure

Kawasaki, Japan and San Jose, USA, September 3, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited, 1Finity Inc., a Fujitsu company and leading provider of global network solutions, and Arrcus Inc., the hyperscale networking software company and a leader in core, edge, and multi-cloud routing and switching infrastructure, today…

Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT

Massachusetts, USA, September 2, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Corporation ("MC”) is pleased to announce its participation in a third-party allotment of shares by Commonwealth Fusion Systems LLC (Headquarter: Massachusetts, USA, Representative: Bob Mumgaard, “CFS”), a fusion energy start-up originating from MIT *1. This investment was made in…

Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework “SAFe(R)”

TOKYO, September 2, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. (TSE:6501, "Hitachi") has been certified as a Gold Partner*1 of Scaled Agile, Inc. ("SAI"), the provider of SAFe®, the world's most trusted system for business agility.SAFe is a management framework that supports organizational transformation and business agility, helping…

FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, MA, August 30, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License…

TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) – Applications for Research Projects Open on September 1

TOKYO, Sept 1, 2025 - (JCN Newswire via SeaPRwire.com) - TANAKA Memorial Foundation (Representative Director: Hideya Okamoto) has announced that it will be accept applications for research themes for FY2025 Precious Metals Research Grants from September 1 to November 28, 2025. This grant program aims to contribute to the development of…

Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma

TOKYO, August 29, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received orphan drug designation for anticancer agent the EZH2*1 inhibitor tazemetostat hydrobromide (generic name, product name “Tazverik® Tablets 200 mg”, “tazemetostat”) for unresectable INI1*2-negative epithelioid sarcoma…

Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage

Completion of strategic acquisition affirms Hitachi Energy’s position as a market and technology leader in advancing energy storage innovation - a cornerstone of secure energy transitionsPower electronics with advanced digital capabilities are critical to ensure reliability and stability of the electric gridZurich, Switzerland, August 28, 2025 - (JCN Newswire via…

SenseTime Announces 2025 Interim Results

HONG KONG, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - SenseTime Group Inc. (“SenseTime” or the “Company”; Stock Code: 0020) announced its interim results today for the six months ended June 30, 2025 (“1H”).In 1H 2025, SenseTime delivered results that exceeded market expectations, with total revenue increasing by 36%…

Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth

HONG KONG, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - On August 27, Ausnutria Dairy Corporation Ltd (Stock Code: 1717.HK, hereinafter referred to as “Ausnutria” or “the Company”) released its 2025 interim results announcement. According to the announcement, from January to June 2025, Ausnutria achieved operating revenue of approximately RMB…

Production, Sales and Export Results for July, 2025

TOKYO, Japan, August 28, 2025 - (JCN Newswire via SeaPRwire.com) – Honda Motor Co., Ltd. today announced a summary of automobile production, Japan domestic sales, and export results for the month of July 2025.For more details, please visit: https://global.honda/content/dam/site/global-en/newsroom-new/cq_img/news/2025/08/c250828beng/c250828beng.pdf  Copyright 2025 JCN Newswire via SeaPRwire.com.